Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99

$74.99/Año

Intentar ORO - Gratis

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$NaN

$NaN/Año

¡Date prisa, oferta por tiempo limitado!

Horas

minutos

artículos de segunda clase

Bio Spectrum - August 2025

Vuélvete ilimitado con Magzter GOLD

Leer Bio Spectrum junto con más de 9000 revistas y periódicos con una sola suscripción

Ver catálogo

1 mes

$14.99

1 año $149.99

$74.99

$6/month

Save 50%
Hurry, Offer Ends in 14 Days

(OR)

Suscríbete sólo a Bio Spectrum

Regalo Bio Spectrum

Cancelar en cualquier momento.

(Sin compromisos) ⓘ

Si no estás satisfecho con tu suscripción, puedes enviarnos un correo electrónico a help@magzter.com dentro de los 7 días posteriores a la fecha de inicio de la suscripción para recibir un reembolso completo. ¡Sin preguntas, lo prometemos! (Nota: No se aplica a compras de números individuales)

Suscripción digital

Acceso instantáneo ⓘ

Suscríbete ahora para comenzar a leer instantáneamente en el sitio web de Magzter, iOS, Android y las aplicaciones de Amazon.

Verificado seguro

pago ⓘ

Magzter es un comerciante verificado de Authorize.Net. Más información

En este número

Can Policy Reforms & Investments Trigger India’s MedTech MAKEOVER?
India’s MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India’s position in the global medical technology (MedTech) landscape?

Centre announces launch of Phenome India "National Biobank"

Union Minister of State (Independent Charge) for Science & Technology (S & T) and Vice President of CSIR, Dr Jitendra Singh, inaugurated the stateof-the-art Phenome India \"National Biobank\" at the CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi.

1 mins

Cabinet approves Research Development and Innovation (RDI) scheme with corpus of Rs 1 lakh crore

In a transformative step to bolster India’s research and innovation ecosystem, the Union Cabinet, chaired by Prime Minister Narendra Modi, has approved the Research Development and Innovation (RDI) Scheme with a corpus of Rs one lakh crore.

1 mins

Punjab launches Data Intelligence & Technical Support Unit to strengthen fight against drugs

In a decisive step towards combating drugs and substance abuse, the Government of Punjab has launched the Data Intelligence and Technical Support Unit (DITSU) - a pioneering initiative under its flagship campaign Yudh Nasheyan Virudh (War Against Drugs).

1 mins

Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26

Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.

1 mins

Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation

Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.

1 mins

Piramal Pharma Solutions breaks ground on $90 M expansion plan in US

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organisation (CDMO) and part of Mumbai-based Piramal Pharma Ltd., recently announced a $90 million investment plan to expand two of its US facilities, which are critical to its integrated offering.

1 mins

AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru

AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.

1 mins

Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab

Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.

1 mins

Rubicon Research completes acquisition of Alkem's Pithampur unit for Rs 149 Cr

Rubicon Research has completed the acquisition of Alkem Laboratories’ formulations manufacturing facility in Pithampur, Madhya Pradesh in an all-cash deal for Rs 149 crore.

1 mins

Novo Nordisk launches injectable Semaglutide for weight management in India

Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.

1 mins

Bharat Biotech to reduce cost of malaria vaccine RTS,S to less than $5

Hyderabad-based Bharat Biotech International Limited (BBIL) and GSK plc have announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world's first malaria vaccine.

1 mins

OMRON and Tricog Health launch KeeboHealth to combat India's cardiac crisis

OMRON Healthcare, a global leader in innovative home health monitoring solutions, has expanded its collaboration with Tricog Health, an AI-driven cardiac care company, to launch KeeboHealthan advanced connected health platform designed to transform remote cardiac care and accelerate progress toward OMRON's ambitious 'Going for Zero' vision - a world with zero cardiovascular events.

1 mins

GTT Data AI Accelerator Network to empower startups in healthcare and life sciences

GTT Data Solutions, a BSE-listed technology enabler known for its Dual Intelligence framework that blends human expertise with advanced artificial intelligence (AI), has launched GAIN (GTT Data AI Accelerator Network), a platform designed to support over 100 AI startups across industries, including a sharp focus on healthcare and life sciences.

1 mins

Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin

Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.

1 mins

LogicFlo AI gets $2.7 M to scale AI agent workforce across global life sciences enterprises

Chennai-based startup LogicFlo AI, an artificial intelligence (AI) platform designed specifically for the life sciences sector, has raised $2.7 million in a seed round led by Lightspeed, with participation from leading healthcare and enterprise AI investors.

1 mins

WHO highlights risks associated with use of semaglutide medicines

The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.

1 mins

WHO certifies Suriname malaria-free

Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).

1 mins

WHO launches bold push to raise health taxes and save millions of lives

The World Health Organization (WHO) has launched a major new initiative urging countries to raise real prices on tobacco, alcohol, and sugary drinks by at least 50 per cent by 2035 through health taxes in a move designed to curb chronic diseases and generate critical public revenue.

1 mins

World leaders recommit to immunisation amid global funding shortfall

At the recently held Global Summit: Health and Prosperity through Immunisation in Brussels, world leaders have pledged support for Gavi, the Vaccine Alliance, leading to a total of more than $9 billion secured against a targeted $11.9 billion budget for its next five-year strategic period from 2026 to 2030 (Gavi 6.0).

1 mins

World-first AI system to warn of NHS patient safety concerns

Patients will receive better care owing to a world-first artificial intelligence (AI) early warning system being developed to automatically identify safety concerns across the National Health Service (NHS) in England, helping stop failures before they escalate.

1 mins

PAHO and SEGIB strengthen partnership for healthier Ibero-America

The Director of the Pan American Health Organisation (PAHO), Dr Jarbas Barbosa, and the Secretary-General of the Ibero-American General Secretariat (SEGIB), Andrés Allamand, have reaffirmed their joint commitment to advancing a more inclusive, equitable, and healthier Ibero-America.

1 mins

US FDA determines safety and effectiveness of immunotherapies

The US Food and Drug Administration (FDA) has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor CAR T cell immunotherapies.

1 mins

Africa unites to take stock of Neglected Tropical Diseases burden

Fifty African Union Member States have endorsed a ground-breaking digital micro-planning portal co-created by Africa Centres for Disease Control and Prevention (Africa CDC) to accelerate the elimination of Neglected Tropical Diseases, a diverse group of infectious diseases that primarily affect impoverished communities in tropical and subtropical areas.

1 mins

Pioneering research to develop all-in-one vaccine against deadly diseases

Scientists at Denmark's AdaptVac will lead the development of a new vaccine that could provide all-in-one protection against multiple deadly viruses including Ebolavirus Zaire, Sudan Ebolavirus and Marburg, all of which cause frequent unpredictable outbreaks in regions of Africa, with significant health and societal impacts and fatality rates of up to 90 per cent.

1 mins

Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?

India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.

10+ mins

Next-generation surgical robotics stand poised for global revolution

The adoption of robot-assisted surgery has increased significantly in the past decade as opportunities for performing minimally invasive procedures have multiplied.

5 mins

Deadly Silence: India's Negligent Pharma Manufacturing Units

Indian pharma manufacturing units are a ticking time bomb. Inflammable chemicals that require special handling are often callously used by ignorant workers leading to reactions, reactor blasts and deaths. Above it, ill-designed setups and less knowledge of hardware and software are taking a toll on the industry. Showing a lackadaisical attitude towards the way manufacturing sites are being operated, Indian pharma companies are at the receiving end of various domestic and global regulators. Overlooking safety issues will lead to more catastrophic events.

7 mins

Accelerated Reliance on Digital Animal Replacement Tech

While Europe is talking about non-animal replacement tests to be used for drug development and research purposes, US FDA is acting upon it with a detailed roadmap aimed at rapidly reducing animal testing in preclinical safety assessments. These developments clearly provide huge opportunities for global companies that are developing alternative methods such as organoids, 3D bioprinting, digital animal replacement technology, computer simulation, to name a few. But where does India stand in this regard, and how skilled are we to make this shift?

4 mins

How Are Indian Institutions Advancing Organoid Research?

For Indian businesses, the combination of robotics and artificial intelligence with organoid technology offers enormous potential for creating automated, scalable organoid production systems.

2 mins

“India is setting a global benchmark with proactive adoption of AI in lab design"

India's life sciences industry is outpacing its global peers when it comes to designing and delivering future-ready lab environments, according to a new survey and report by Unispace, a global leader in strategy, design, and construction of workplace environments.

5 mins

Can Algae Transform Tomorrow's Science & Medicine?

More than two-thirds of our planet is covered by water, encompassing vast oceans, lakes, and rivers, yet much of this underwater world remains a mystery, with large regions still unexplored and ecosystems waiting to be discovered.

4 mins

Quantum Sensing and Healthcare: Charting India's Next Frontier

Quantum sensing can revolutionise healthcare by enabling early disease detection, precise diagnostics, and customized treatment plans. It detects subtle changes in fields, improving diagnoses for various diseases.

4 mins

Digital Personal Data Protection Act (DPDPA) – A Wake-Up Call for IVF Clinics

With the introduction of the Digital Personal Data Protection Act, 2023 (DPDPA), questions are being raised about how India's earlier medical laws handle patient data and privacy.

3 mins

Nanozymes: The Next Generation of Artificial Enzymes

Since their discovery in the early 2000s, nanozymes have gained attention for their durability under extreme conditions and versatility in applications ranging from medicine to industry. Made from materials like metal oxides, noble metals, and carbon nanostructures, nanozymes are redefining the future of catalysis and biochemistry.

2 mins

How Can Labs Reduce Their Energy Consumption?

Research labs can concentrate on innovation by collaborating with infrastructure providers, leaving waste, water, and energy management to professionals.

2 mins

Quadria Group appoints Rahul Agarwal as Partner at HealthQuad

Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Rahul Agarwal as Partner at HealthQuad, India's leading healthcare-focused growth venture capital platform.

1 mins

INSA Women Associates names Dr Prajakta Dandekar Jain as Founding Member

The Institute of Chemical Technology (ICT), Mumbai, has announced the selection of Dr Prajakta Dandekar Jain, UGC Assistant Professor at the Department of Pharmaceutical Sciences and Technology, as a Founding Member of the newly constituted INSA Women Associates (IWA) by the Indian National Science Academy (INSA), New Delhi.

1 mins

Asia Healthcare Holdings names Arvind N Sivaramakrishnan as CTO

Asia Healthcare Holdings (AHH), a leading operating platform for single specialty healthcare in India & South Asia, has announced the appointment of Arvind N Sivaramakrishnan as its Chief Technology Officer (CTO).

1 mins

Scientists in Guwahati reveal hidden healing power of poisonous plants

Researchers at the Institute of Advanced Study in Science and Technology (IASST), Guwahati, an autonomous institute of the Department of Science and Technology (DST), are tracing the secrets held in the leaves, roots, and sap of the natural world, having comprehensively investigated various poisonous plant species and their phytochemical constituents.

1 mins

CeNS designs pocketsized sensor to detect health threats in air

Scientists from Centre for Nano and Soft Matter Sciences (CeNS), Bengaluru, an autonomous institute of Department of Science and Technology (DST), have fabricated a sensor by combining two metal oxides-nickel oxide (NiO) and neodymium nickelate (NdNiO3), through a simple synthesis process.

1 mins

IISc develops simple sensor for liver cancer detection

Researchers at the Indian Institute of Science (IISc), Bengaluru have developed a unique luminescent probe that uses terbium, a rare earth metal, to sense the presence of an enzyme called -glucuronidase, which can potentially aid in the detection of liver cancer.

1 mins

Illumina buys SomaLogic for $425 M to accelerate proteomics business

Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.

1 mins

Xcell Biosciences collaborates with Thermo Fisher to advance next generation of cell therapies

Xcell Biosciences, a US-based instrumentation company focused on cell and gene therapy applications, has announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, to advance research in regulatory T cells (Tregs) and tumour-infiltrating lymphocytes (TILs).

1 mins

Ecolab Life Sciences unveils new bioprocessing purification resin

US-based Ecolab Life Sciences has launched an innovative new resin to help achieve cost savings and optimise operations throughout the antibody manufacturing process.

1 mins

Revvity introduces new IVD reference standards for oncology testing

Revvity, Inc. has announced the launch of three Mimix reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from human samples for IVD use.

1 mins

Waters launches Xevo TQ Absolute XR Mass Spectrometer

Waters Corporation has announced the launch of the Xevo TQ Absolute XR Mass Spectrometer, the company's most sensitive, robust, and reliable benchtop tandem quadrupole.

1 mins

Bionova Scientific expands capacity and enters advanced therapies market

Bionova Scientific, a contract development and manufacturing organisation (CDMO), is entering the advanced therapy manufacturing space.

1 mins

Transformative 'Quantum' Leap in Healthcare

With the healthcare sector facing complex challenges that call for innovative solutions to improve diagnostic accuracy, treatment efficacy, and data management, we see quantum technology, with its unique capabilities, holding the potential to revolutionise various aspects of healthcare.

2 mins

Lea todas las historias de Bio Spectrum

Bio Spectrum Description:

Editor: MM-Activ-Sci-Tech-Communication

Categoría: Business

Idioma: English

Frecuencia: Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.